Acro Biomedical (ACBM) Change in Receivables (2021 - 2023)
Acro Biomedical's quarterly Change in Receivables came in at -$18500.0 in Q3 2023, up 97.01% year-on-year from -$9390.3 in Q3 2022, and up 83.18% quarter-over-quarter from -$110000.0 in Q2 2023.
Acro Biomedical has reported Change in Receivables for 3 years, with the latest figure at -$18500.0 in Q3 2023.
- For the quarter ending Q3 2023, Change in Receivables rose 97.01% year-over-year to -$18500.0; the trailing twelve-month figure through Jun 2024 stood at -$18500.0 (up 95.36% YoY), and the FY2023 full-year result was -$158500.0, down 491.36% from the prior year.
- Change in Receivables for Q3 2023 stood at -$18500.0, up from -$110000.0 in the prior quarter.
- The five-year high for Change in Receivables was $599000.0 in Q2 2022, with the low at -$619000.0 in Q3 2022.
- Average Change in Receivables over 3 years is -$89500.0, with a median of -$70000.0 recorded in 2023.
- Year-over-year, Change in Receivables surged 160.2% in 2022 and sank 118.36% in 2023.
- Tracing ACBM's Change in Receivables over 3 years: stood at -$598000.0 in 2021, then surged by 160.2% to $360000.0 in 2022, then slumped by 105.14% to -$18500.0 in 2023.
- The last three Change in Receivables figures came in at -$18500.0 (Q3 2023), -$110000.0 (Q2 2023), and -$30000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -18,500.00 |
| Sep 30, 2023 | -18,500.00 |
| Jun 30, 2023 | -110,000.00 |
| Jun 30, 2023 | -110,000.00 |
| Mar 31, 2023 | -30,000.00 |
| Mar 31, 2023 | -30,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Sep 30, 2022 | -619,000.00 |
| Sep 30, 2022 | -619,000.00 |
| Jun 30, 2022 | 599,000.00 |
| Jun 30, 2022 | 599,000.00 |
| Mar 31, 2022 | -299,500.00 |
| Mar 31, 2022 | -299,500.00 |
| Dec 31, 2021 | -598,000.00 |
| Dec 31, 2021 | -598,000.00 |